에 대한 최신 뉴스 Markforged Holding (NYSE:MKFG) 주식

Markforged Holding

Markforged Holding Corp transforms manufacturing with 3D metal and continuous carbon fiber printers capable of producing parts tough enough for the factory floor. intuitive additive manufacturing platform for modern manufacturers, bringing the power and speed of agile software development to industrial manufacturing. Composed of hardware, software and materials working as a unified platform. It operates in industries such as Aerospace, Automotive, Consumer Packaged Goods, Education and Research, Electronics Manufacturing, Energy, Federal and Defense, Industrial Equipment. The company's geographical segments include the Americas; Europe, the Middle East, Africa; and Asia-Pacific. It derives maximum revenue from Americas.

Equities

News

Markets

ETFs

ARCT

ARKK

ARKQ

ARKW

BLDE

MKFG

NVDA

ROKU

2024년 6월 25일 화요일, 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 상당한 시장 변동성 속에서 엔비디아(NASDAQ:NVDA)와 로쿠(NASDAQ:ROKU)에서 상당한 거래를 했다. 이러한 거래는 아크의 다양한 ETF가 이행한 일련의 거래의 일부였다.

아크 인베스트는 주가 반등 속에 엔비디아 주식에서 $430만 매도, 로쿠 주식을 매수

$BTC

$ETH

ARKF

ARKG

ARKX

HOOD

TDOC

VERV

캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 수요일에 로빈후드 마켓(NASDAQ:HOOD) 및 줌 비디오 커뮤니케이션(NASDAQ:ZM)괴 관련하여 상당한 거래를 했다.
로빈후드 주식의 거래

아크 인베스트는 로빈후드 주식 150만 달러를 매도하며, 줌 주식 330만 달러 상당도 처분

Markforged Holding Corporation Common Stock

Markforged Holding Corp

Markforged Holding Corp Warrants (17/08/2025)

Barclays analyst Lauren Lieberman maintains BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) with a Overweight and raises the price target from $74 to $79.

Price Target

Analyst Ratings

BRBR

Barclays Maintains Overweight on BellRing Brands, Raises Price Target to $79

WIIM

VNET

VNET Group shares are trading higher after the company reported Q3 EPS and revenue that rose year-over-year.

Barclays analyst Brian Morton maintains Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) with a Overweight and raises the price target from C$126 to C$143.

TSX:BMO

Barclays Maintains Overweight on Bank of Montreal, Raises Price Target to C$143

On Wednesday, the FDA granted accelerated approval to Jazz Pharmaceuticals plc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use for adults with previously treated, unresectable, or metastatic HER2-positive (IHC 3+) <a href="https://www.benzinga.com/pressreleases/24/11/n42101689/jazz-pharmaceuticals-announces-u-s-fda-approval-of-ziihera-zanidatamab-hrii-for-the-treatment-of-a" target="_blank" rel="noreferrer noopener">biliary tract cancer (BTC)</a>.
Ziihera&nbsp;was approved under accelerated approval based on a 52% objective response rate (ORR) and a median duration of response (DOR) of 14.9 months.
Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41338366/jazz-pharmaceuticals-zepzelcatecentriq-combo-regimen-can-potentially-delay-disease-progression-ex" rel="noreferrer noopener">Jazz Pharmaceuticals&#8217; Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer</a>
The Phase 3 HERIZON-BTC-302 confirmatory trial is ongoing to evaluate zanidatamab in combination with standard-of-care therapy versus standard-of-care therapy alone in the first-line setting for patients with HER2-positive BTC.
Regulatory reviews of zanidatamab for BTC remain ongoing in China and Europe.
In late 2022, Zymeworks Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) entered into a license and collaboration agreement with Jazz Pharmaceuticals for the exclusive development and commercialization rights to zanidatamab across all indications in the United States, Europe, Japan, and all other territories except for those Asia Pacific territories previously <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42106981/fda-grants-u-s-approval-of-ziihera-zanidatamab-hrii-for-the-treatment-of-adults-with-previously-tr" rel="noreferrer noopener">licensed by Zymeworks</a>.
Under the Jazz license and collaboration agreement terms, Zymeworks has earned a milestone payment of $25 million based on the FDA approval in BTC. Zymeworks is also eligible to receive up to a further $500 million in regulatory milestone payments and $862.5 million in commercial milestone payments, as well as tiered royalties of 10% to 20% of net sales by Jazz.
Zymeworks says the approval represents the first FDA-approved therapy in its pipeline and validates the company&#8217;s Azymetric bispecific platform technology.
Price Action: JAZZ stock closed at $119.24 on Wednesday. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42097813/eli-lilly-opts-to-develop-candidate-for-nervous-system-disease" target="_blank" rel="noreferrer noopener">Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate</a></li>
</ul>
Photo: Shutterstock

Biotech

Large Cap

Health Care

General

JAZZ

ZYME

FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework

Universal Technical Institute shares are trading higher after the company reported better-than-expected Q4 EPS and sales, and provided FY2024 revenue guidance above analyst estimates.

AppLovin shares are trading higher after the company priced a public offering of $3.55 billion in senior notes.

In Anaheim at the recent <a href="https://cannabismarketspotlight.com/california/anaheim-november-12/">Cannabis Market Spotlight: California </a>event, seasoned cannabis entrepreneur Seth Yakatan shared his perspective on the cannabis industry's current landscape and future potential. 
Despite recent shifts in cannabis stock prices, Yakatan believes the sector remains fundamentally stable. "The technical fundamentals of the sector pretty much remained the same," he noted, adding that he saw the price drop as an opportunity and "just bought more stocks cheaper."
<h4 class="wp-block-heading">Federal Policy and a Cautious Outlook</h4>
Looking ahead, Yakatan discussed the impact of upcoming federal decisions on the cannabis industry. He remains "cautiously optimistic" but believes it could be March before any clear direction emerges. 
Yakatan highlighted three key areas to watch: the selection of a new Attorney General, possibly reclassifying cannabis to Schedule III and ongoing legislative changes in states like Pennsylvania. "Anything other than that's probably just speculation," he remarked, stressing that the path forward depends on these developments.
<h4 class="wp-block-heading">California's Market Leads the Way</h4>
Yakatan also expressed confidence in California's enduring position as a leader in the U.S. cannabis market, calling it "still the biggest cannabis market in the United States." 
Although he acknowledged challenges within California's market, he emphasized the dedication of long-standing businesses that continue to secure investment and make strides in the industry. "I don't see that dynamic changing," Yakatan stated, underscoring his confidence in California's cannabis market to continue thriving.
Yakatan's observations at the event reflected the optimism shared by many industry experts, signaling a resilient future for cannabis even as it faces a complex regulatory environment.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42111313/exclusive-fluent-launches-new-cannabis-concentrates-line-for-medical-marijuana-patients-in-florida">FLUENT Launches New Cannabis Concentrates Line For Medical Marijuana Patients In Florida</a></li>
</ul>
Image: AI-Generated Image

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Events

Exclusives

Interview

California's Cannabis Future: Why One Expert Believes The Market Will Hold Strong

Piper Sandler analyst David Amsellem reiterates Jazz Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) with a Overweight and lowers the price target from $166 to $163.

Reiteration

Piper Sandler Reiterates Overweight on Jazz Pharmaceuticals, Lowers Price Target to $163

Barclays analyst Alex Scott maintains Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) with a Equal-Weight and raises the price target from $300 to $308.

Barclays Maintains Equal-Weight on Arthur J. Gallagher, Raises Price Target to $308

Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are trading higher on Thursday. The company announced it submitted a <a href="https://www.benzinga.com/pressreleases/24/11/b42099063/super-micro-computer-inc-nasdaq-non-compliance-update">compliance plan to the Nasdaq</a>.
What Happened: After the market close on Wednesday, Super Micro said it submitted a compliance plan to the Nasdaq after receiving a notification letter that it was not in compliance with the Nasdaq&#8217;s timely filing rule. The plan was submitted on Monday with respect to supporting the company&#8217;s request for an extension to regain compliance.
Super Micro said in the compliance plan that it believes it will be able to file both its annual report for the fiscal year ended June, 30 2024 and its quarterly report for the period ended Sept. 30, 2024 within the discretionary period that can be granted by the Nasdaq.
See Also: <a href="https://www.benzinga.com/news/earnings/24/11/42109965/baidus-q3-earnings-revenue-slides-weak-online-ads-market-impact-margins">Baidu&#8217;s Q3 Earnings: Revenue Slides, Weak Online Ads Market Impact Margins</a>
The update comes after the company&#8217;s independent auditor resigned at the end of October over&nbsp;<a href="https://www.benzinga.com/quote/SMCI" target="_blank" rel="noreferrer noopener">governance and transparency concerns</a>. 
Super Micro on Monday announced that it <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42069253/supermicro-stock-is-rising-tuesday-whats-going-on">appointed BDO USA</a> as its new independent auditor, effective immediately.
&#8220;BDO is a highly respected accounting firm with global capabilities.&nbsp;This is an important next step to bring our financial statements current, an effort we are pursuing with both diligence and urgency,&#8221; said&nbsp;Charles Liang, president and CEO of SuperMicro.
Super Micro has faced significant selling pressure since the company&#8217;s auditor raised concerns. The stock traded all the way down to around $17.25 per share last week before bouncing back. Super Micro shares are now up more than 43% over the past five trading sessions.
SMCI Price Action: Super Micro shares were up 5.23% at $27.18 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

SMCI

Super Micro Computer Stock Is Rallying Thursday: What's Going On?

LAZR

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Piper Sandler analyst Adam Butler assumes Farmers National Banc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMNB#NASDAQ">FMNB</a>) with a Neutral rating and announces Price Target of $17.

Initiation

FMNB

Piper Sandler Assumes Farmers National Banc at Neutral, Announces Price Target of $17

Barclays analyst Alex Scott maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Overweight and raises the price target from $394 to $440.

Barclays Maintains Overweight on Aon, Raises Price Target to $440

Agrify Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGFY#NASDAQ">AGFY</a>) shares are trading lower by 23.9% to $29.50 Thursday morning after the company announced it secured approximately $25.9 million through a <a href="https://www.benzinga.com/pressreleases/24/11/g42108171/agrify-announces-25-9-million-non-brokered-private-placement">non-brokered private placement</a>.
What Happened: The deal, priced at $22.30 per share, involves securities purchase agreements with institutional and accredited investors. The proceeds will support general corporate purposes, including working capital and business development.
The private placement, expected to close on November 21, includes participation from Chairman and Interim CEO Benjamin Kovler, who purchased 10,000 shares at $38.76 each in accordance with Nasdaq requirements.
Kovler emphasized the strategic significance of the funding, calling it a &#8220;strong move&#8221; for the company and shareholders. &#8220;We plan to channel this capital into areas within our expertise to maximize shareholder value,&#8221; he said, highlighting optimism around cannabis and hemp consumer trends. 
Kovler also confirmed progress on the company&#8217;s pending Señorita transaction, which is anticipated to close by year-end.
Read Also: <a href="https://www.benzinga.com/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan">The U.S. Cannabis Strategy No One&#8217;s Talking About: Inside Canopy&#8217;s $300M Plan</a>
<h2 class="wp-block-heading">Should I Sell My AGFY Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> 
AGFY has a 52-week high of $42.00 and a 52-week low of $2.71.

AGFY

Why Agrify (AGFY) Stock Is Getting Hammered

CGNT

Cognyte Secures $2M+ Follow-On Order From Leading North American Law Enforcement Agency, Bringing Total Investment To $3M As Agency Replaces Incumbent Provider For Enhanced Threat Detection And Operational Intelligence

Warner Music Group shares are trading lower after the company reported worse-than-expected Q4 EPS results.

KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) shares are trading higher premarket on Thursday. The company led a $370 million growth investment in Lighthouse, a commercial intelligence platform<a href="https://www.benzinga.com/pressreleases/24/11/b42104948/lighthouse-announces-370-million-series-c-investment-led-by-kkr-to-accelerate-platform-innovation-" target="_blank" rel="noreferrer noopener"> for the travel and hospitality industry</a>.
This funding will propel Lighthouse&#8217;s efforts to transform commercial strategy within the $15 billion travel and hospitality technology sector. 
The investment will be allocated towards further product innovation, strategic acquisitions, and expanding Lighthouse's global presence.
Notably, KKR has a proven track record of investing $23 billion in technology-focused growth companies since 2010, which will help Lighthouse expand globally.
Sean Fitzpatrick, CEO of Lighthouse said, &#8220;This investment by KKR significantly accelerates our ability to enhance our commercial platform through expanded AI capabilities and additional data sets, enabling us to better serve our existing customers while continuing to expand across the hospitality market.&#8221;
Yesterday, KKR launched the second stage of its tender offer for FUJI SOFT INCORPORATED shares and share options, which started on November 20, 2024, and will <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42083136/kkr-commences-second-tender-offer-for-fuji-soft" rel="noreferrer noopener">run until December 19, 2024</a>.
The tender offer price is 9,451 yen per common share and varies for share options, with prices set at 1,197,200 yen for the 5th Series, 1,059,800 yen for the 6th Series, and 293,200 yen for the 7th Series.
Investors can gain exposure to KKR via&nbsp;FM Focus Equity ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMCX#NYSE">FMCX</a>) and&nbsp;EA Series Trust WHITEWOLF Publicly Listed Private Equity ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/LBO#BATS">LBO</a>).
Price Action: KKR shares are up 1.19% at $153.99&nbsp;premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/ma/24/11/42025534/deal-dispatch-shell-unilever-and-more-are-on-the-sell-side-the-onion-makes-alex-jones-cry-foul" target="_blank" rel="noreferrer noopener">Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul</a></li>
</ul>

Northern Lights Fund Trust IV FMC Excelsior Focus Equity ETF

FMCX

KKR Inks $370 Million Investment, Propels Lighthouse's Global Hospitality Ambitions

Roth MKM analyst Bill Kirk maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Neutral and lowers the price target from $157 to $131.

Roth MKM Maintains Neutral on Target, Lowers Price Target to $131

CETY

Clean Energy Technologies shares are trading higher after the company announced a strategic partnership with METIS Power to develop advanced microgrid solutions for AI data centers and cryptocurrency mining operations.

GRAB

Grab Holdings shares are trading lower after China Renaissance downgraded the stock from Buy to Hold.

Markforged enters into settlement agreement with Continuous Composites

The latest announcement is out from Markforged Holding ( ($MKFG) ). Markforged Holding Corporation has reached a comprehensive Settlement and Paten...

Markforged Resolves Lawsuit with Patent License Deal

In a report released today, Greg Palm from Craig-Hallum maintained a Hold rating on Markforged Holding (MKFG – Research Report), with a price targe...

Markforged Holding (MKFG) Gets a Hold from Craig-Hallum

Nano Dimension to acquire Markforged in all-cash deal

An update from Markforged Holding ( ($MKFG) ) is now available. Nano Dimension Ltd. has announced the acquisition of Markforged Holding Corporation...

Markforged Acquisition by Nano Dimension Strengthens 3D Printing Industry

Nano Dimension: Revenue To Jump With Desktop Metal And Markforged Acquisitions

Murchison, a significant shareholder with approximately 7.1% of the outstanding shares of Nano Dimension (NNDM), announced it has nominated two dir...

Murchison nominates two candidates to Nano Dimension's board

Markforged Holding GAAP EPS of -$1.15 misses by $0.44, revenue of $20.48M misses by $2.06M

Reports Q3 revenue $20.48M, consensus $22.54M. "We are pleased with our results in Q3 that were supported by the encouraging adoption of our latest...

Markforged reports Q3 EPS ($1.15), consensus (48c)

Markforged Holding Corporation ( ($MKFG) ) has released its Q3 earnings. Here is a breakdown of the information Markforged Holding Corporation pres...

Markforged's Q3 2024 Results and Strategic Moves

NNDM

Press Releases

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Markforged Holding Corporation

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMAR, MKFG, KAVL, ITI on Behalf of Shareholders

MARKFORGED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Markforged Holding Corporation - MKFG

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, MKFG, KAVL on Behalf of Shareholders

Earnings

Nano Dimension Announces Strong Preliminary Q3/2024 Results

Murchinson Nominates Two Highly Qualified Candidates to Nano Dimension's Board of Directors

Markforged Sets Reporting Date for Third Quarter 2024 Financial Results

Markforged Announces Third Quarter 2024 Results

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, PIK, MKFG, PFC on Behalf of Shareholders

$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, VBFC, CFB and MKFG

BTTR

CYTH

INSG

KAVL

SEAC

SMAR

SSYS

VBFC

Nuburu

ClearSign Technologies Corporation - Common Stock

ClearSign Technologies

Chicago Rivet & Machine

3D Sys

Desktop Metal

Eastern

L.B. Foster

Gencor Industries

Greenland Technologies Holding Corporation - Ordinary Shares

Greenland Technologies

Highway Holdings

Hurco Companies

Laser Photonics Corporation - Common Stock

Laser Photonics

Li Bang International Corporation Inc. - Ordinary Shares

Li Bang International

LiqTech International, Inc. - Common Stock

LiqTech Intl

Mayville Engineering Company, Inc. Common Stock

Mayville Engineering

Nephros

Palladyne AI

Perma-Pipe International Holdings, Inc. - Common Stock

Perma-Pipe Inlt Hldgs

Richtech Robotics Inc. - Class B Common Stock

Richtech Robotics

374Water

Taylor Devices

Techprecision

ZJK Industrial Co., Ltd. - Ordinary Shares

ZJK Industrial

CleanCore Solutions Inc. Class B Common Stock

CleanCore Solutions

Cantor Fitzgerald

Credit Suisse

Citigroup

Goldman Sachs

2024년 6월 25일 화요일, 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 상당한 시장 변동성 속에서 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)와 로쿠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>)에서 상당한 거래를 했다. 이러한 거래는 아크의 다양한 ETF가 이행한 일련의 거래의 일부였다.
엔비디아 거래
이 회사의 ARK 자율 기술 및 로봇공학 ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>)는 화요일에 엔비디아 주식 33,834주를 매각했다. 거래 규모는 430만 달러에 이른다. 이날 엔비디아 주가는 6.8% 오른 126.09달러로 마감했다.
이러한 움직임은 목요일 이후 <a href="https://www.benzinga.com/top-stories/24/06/39490865/nvidia-rebounds-over-6-after-550b-market-cap-loss">5500억 달러</a>의 감소를 보인 이 기술 대기업의 상당한 시가총액 손실에 따른 것이다. 그럼에도 불구하고 엔비디아는 화요일에 6% 이상 반등하여 마이크로소프트와 애플에 이어 세 번째로 가치 있는 기업으로서의 위치를 ​​되찾았다.
S&amp;P 500 지수에 대한 엔비디아의 영향력에 대한 우려가 제기되었으며, 일부 분석가들은 이 회사가 상당한 매도세를 겪을 경우 잠재적인 시장 침체가 더욱 확대될 수 있다고 <a href="https://www.benzinga.com/trading-ideas/technicals/24/06/39482710/nvidia-stock-drops-over-12-in-3-trading-days-indicators-suggest-whats-next">경고</a>했다. 이러한 우려에도 불구하고 엔비디아의 펀더멘털은 여전히 ​​강력하며, 데이터 센터와 자동차 부문의 강력한 성과에 힘입어 2024년 1분기 실적이 월스트리트의 기대치를 뛰어넘었다.
로쿠 거래
ARK 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)와 ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 화요일에 530만 달러 상당의 거래를 통해 로쿠의 주식 96,465주를 매입했다. 로쿠의 주가는 화요일 정규 세션에서 0.35% 상승한 54.64달러로 마감했다.
이러한 움직임은 최근 로쿠의 주가가 <a href="https://www.benzinga.com/general/entertainment/24/06/39422115/roku-stocks-wild-ride-bullish-analysts-bet-on-growth-despite-competitive-threats">강한 매수-매도 논쟁</a>에 휘말리면서 로쿠의 격동적인 시장 상황 속에서 이루어졌다. 경쟁적 위협에도 불구하고 낙관적인 투자자들은 여러 측면에서 로쿠의 수익 잠재력에 열광하고 있다.
로쿠의 라이벌인 넷플릭스는 최근 광고 인벤토리와 광고주 수요를 직접 연결하도록 설계된 <a href="https://www.benzinga.com/markets/equities/24/06/39295418/whats-going-on-with-tv-streaming-platform-rokus-shares-on-wednesday" target="_blank" rel="noopener">광고 기술 솔루션</a>인 로쿠 익스체인지(Roku Exchange)를 공개했다. 이 플랫폼은 스트리밍 우선 광고 기술의 상당한 발전을 나타내며 시장에서 로쿠의 입지를 더욱 공고히 한다.
기타 주요 거래:
<ul>
<li>아크 인베스트의 ARKG펀드가 깅코 바이오웍스 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NASDAQ">DNA</a>)의 상당량의 주식을 매도했다. ARKG는 또한 아크투루스 테라퓨틱스 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>)와 10X 지노믹스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>)의 주식을 매수했다.</li>
<li>ARKK 펀드는 줌 비디오 커뮤니케이션즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) 주식을 매도했으며, 페이저듀티(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) 주식을 매수했다. ARKQ는 블레이드 에어 모빌리티(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>)와 마크포지드 홀딩(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NASDAQ">MKFG</a>)의 주식을 매수했다.</li>
</ul>
본 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 통해 작성되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>이 편집했습니다.

캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 수요일에 로빈후드 마켓(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) 및 줌 비디오 커뮤니케이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>)괴 관련하여 상당한 거래를 했다.
로빈후드 주식의 거래
아크 인베스트는 Ark Fintech Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)와 ARK Next Generation Internet ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)를 통해 약 153만 달러 상당의 로빈후드 주식 64,706주를 매각했다. 이러한 움직임은 이 회사가 최근 시장 변동으로 인해 로빈후드의 <a href="https://www.benzinga.com/markets/equities/24/06/39263031/cathie-wood-lead-ark-invest-dumps-7-6m-worth-of-robinhood-shares-amid-gamestop-buzz-bitcoin-chop">보유 지분</a>을 줄인 후에 나온 것이다. 이 회사의 주가는 현재 5월 영업 데이터 발표 이후 상승하고 있다.
특히 로빈후드 거래는 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)과 이더리움(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)의 가격이 약간의 상승세를 보였지만 연방준비은행(연준)의 금리 인하에 대한 매파적인 지침으로 인해 <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39303902/bitcoin-ethereum-dogecoin-fail-to-sustain-uptrend-after-feds-hawkish-guidance-analyst-fore" target="_blank" rel="noopener" data-google-interstitial="false">이 랠리는 지속되지 않았다</a>.
줌 주식 거래
아크 인베스트는 ARKW를 통해 54,165주, 약 330만달러 상당의 줌 주식을 매도했다. 이 결정은 회사가 지난달 <a href="https://www.benzinga.com/news/earnings/24/05/38926994/zoom-q1-earnings-revenue-beat-eps-beat-cash-flow-surges-continued-ai-integration-and-more">매출과 이익 예상치를 뛰어넘는 강력한 1분기 실적을 발표한 </a>이후의 결정이다.
다른 중요한 거래들:
<ul>
<li>아크 인베스트는 마크포지드 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>)의 주식 21,260주를 ARK Autonomous Technology &amp; Robotics ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>)를 통해 매수했다. 아크 인베스트는 ARK Space Exploration &amp; Innovation ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>)를 통해 마크포지드 8,776주를 구매했다.</li>
<li>아크 인베스트는 페이저듀티(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>)의 주식 15,383주를 ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)를 통해 구매했다. 아크 인베스트는 ARK Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)를 통해 아크투러스 테라퓨틱스 홀딩스(NASDAQ:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/arct" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for ARCT">ARCT</a>)주식 39,589주를 매수했다.</li>
<li>아크 인베스트는 ARKW ETF를 통해 텔레닥 헬스 주식 229,654주를 매도했다. 아크 인베스트는 ARKK ETF를 통해 버브 테라퓨틱스 주식 125,257주를 매도했다. 이 회사는 ARKG ETF를 통해 버브 테라퓨틱스 주식 24,866주를 매도했다.</li>
</ul>
본 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 통해 제작되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>이 수정했습니다.

Comments

Markforged Holding

뉴스

에 대한 최신 뉴스 Markforged Holding (NYSE:MKFG) 주식

수요일, 6월 26, 2024

목요일, 6월 13, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌